Sotera Health Company Down 2.78% To $16.59 After Earnings Meet

Sotera Health Co (SHC) missed earnings estimates for Q4 2023 this morning.

The consensus among analysts for Sotera Health Company was for an earnings per share (EPS) of $0.26. The firm failed to meet those projections, reporting an EPS of $0.26, a neutral surprise of $0. Profits rose 4% year-over-year after reporting an EPS of $0.25 in its year-ago quarter. The positive growth rate signals that the Healthcare company is performing decently amid recent economic conditions.

Analyst projections for Sotera Health Company revenue came in at a consensus of $302.2 million. Fourth-Quarter revenues surpassed estimates for $310.2 million by $8.1 million (3%). The company achieved 23% growth year-over-year compared to the firm’s revenue of $251.6 million from the year-ago quarter. The lower earnings growth relative to revenue signals Sotera Health Company has not been able to improve its profit margin.

The stock is down 2.78% to $16.59 after the report.

The firm’s higher revenue growth to earnings signals that the firm has not been able to reduce costs and has seen its profit margin decrease.

The average recommendation from Wall Street analysts was a Buy which may get revised based on this new data.

Trading in the five days leading up to the report earned Sotera Health Company a Bullish Sentiment Rank from InvestorsObserver.

Sotera Health Company has performed a little above average during the past few months. Before the report, Sotera Health Company received a Long-Term Technical Rank by InvestorsObserver of 55, putting it in the top half of stocks. The firm set a 52-week low on October 27, 2023 at $12.34 and set a 52-week high on July 19, 2023 at $19.4.

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety, and advanced applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are United States, Canada, Europe, and other regions.


More from this stream


‘Infrastructure division bolstered by Geobear’

Ground engineering and subsidence specialist Geobear has recruited Arcadis technical director Paul Garthwaite. Paul Garthwaite Paul Garthwaite...

The Future of Business with e-Signature Adoption

In the fast-paced world of modern business, adopting digital tools and solutions is not just an option but a necessity for staying efficient. Among the numerous advancements, e-signature solutions have emerged as a cornerstone technology that enables companies to streamline their operations, lower costs, and improve security. This technology facilitates signing documents electronically, eliminating the […]

The post Future of Business with e-Signature Adoption appeared first on Insights Success.

‘Leading Chinese Online Portal Emerges Victorious in Fierce Competition’, one of the most prominent online portals in China, continues to solidify its position in the digital landscape. With a diverse range of services and a user-friendly interface, the website...

‘Platform Revolutionizing Online Publishing’, the popular online publishing platform, has gained immense popularity among writers, journalists, and readers alike. With a mission to elevate the quality of online content and build a...

Key to Searching for Alien Life Could Lie in Purple Planets, Not Green Ones

Science fiction films have shaped our collective imagination into believing that any planet harboring extra-terrestrial life would look like a lush green utopia, somewhat like Earth....